消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2021 ESGE/ESGENA立场声明：胃肠内镜检查和COVID-19（疫苗和病毒变异时代的更新）

2021-12-21 欧洲胃肠道内窥镜学会 Endoscopy

胃肠内镜检查

2021年12月，欧洲胃肠道内窥镜学会(ESGE)联合欧洲胃肠病和内窥镜护理联合学会(ESGENA)更新了胃肠内镜检查和COVID-19的立场声明。

中文标题：

2021 ESGE/ESGENA立场声明：胃肠内镜检查和COVID-19（疫苗和病毒变异时代的更新）

英文标题：

ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: Updated guidance for the era of vaccines and viral variants

发布机构：

欧洲胃肠道内窥镜学会

发布日期：

2021-12-21

简要介绍：

2021年12月，欧洲胃肠道内窥镜学会(ESGE)联合欧洲胃肠病和内窥镜护理联合学会(ESGENA)更新了胃肠内镜检查和COVID-19的立场声明。通过接种疫苗策略，COVID-19的流行已进入一个新阶段。但传播性增强的病毒变异已经成为世界各地流行的主要驱动因素。本文主要针对在COVID-19流行期间行胃肠内镜检查的护理和防护提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2021 ESGE_ESGENA立场声明：胃肠内镜检查和COVID-19（疫苗和病毒变异时代的更新）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=0192b1c002300984, title=2021 ESGE/ESGENA立场声明：胃肠内镜检查和COVID-19（疫苗和病毒变异时代的更新）, enTitle=ESGE and ESGENA Position Statement on gastrointestinal endoscopy and COVID-19: Updated guidance for the era of vaccines and viral variants, guiderFrom=Endoscopy, authorId=0, author=, summary=2021年12月，欧洲胃肠道内窥镜学会(ESGE)联合欧洲胃肠病和内窥镜护理联合学会(ESGENA)更新了胃肠内镜检查和COVID-19的立场声明。, cover=https://img.medsci.cn/20211224/1640352600847_1608702.jpg, journalId=0, articlesId=null, associationId=434, associationName=欧洲胃肠道内窥镜学会, associationIntro=欧洲胃肠道内窥镜学会（ESGE，European Society of Gastrointestinal Endoscopy）致力于通过研讨会、出版指南、临床研究等发展先进的内窥镜技术。它代表了欧洲国际性内窥镜组织，地中海地区和北非团体均有加入的资格。, copyright=0, guiderPublishedTime=Tue Dec 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年12月，欧洲胃肠道内窥镜学会(ESGE)联合欧洲胃肠病和内窥镜护理联合学会(ESGENA)更新了胃肠内镜检查和COVID-19的立场声明。通过接种疫苗策略，COVID-19的流行已进入一个新阶段。但传播性增强的病毒变异已经成为世界各地流行的主要驱动因素。本文主要针对在COVID-19流行期间行胃肠内镜检查的护理和防护提供指导建议。</span></p>, tagList=[TagDto(tagId=60302, tagName=胃肠内镜检查)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=76, categoryName=胃肠外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=60302, guiderKeyword=胃肠内镜检查, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1791, appHits=45, showAppHits=0, pcHits=231, showPcHits=1746, likes=0, shares=5, comments=5, approvalStatus=1, publishedTime=Fri Dec 24 21:25:54 CST 2021, publishedTimeString=2021-12-21, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=dajiong, createdTime=Fri Dec 24 21:35:12 CST 2021, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 02:14:32 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ESGE_ESGENA立场声明：胃肠内镜检查和COVID-19（疫苗和病毒变异时代的更新）.pdf)])
2021 ESGE_ESGENA立场声明：胃肠内镜检查和COVID-19（疫苗和病毒变异时代的更新）.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1180403, encodeId=417d11804035c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df896443924, createdName=ms5000000675684069, createdTime=Tue Jan 04 14:32:06 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179607, encodeId=5f3a11e9607f1, content=值得下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:39 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179606, encodeId=55d111e9606ba, content=好东西，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:33 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179605, encodeId=bb7c11e960540, content=主要驱动因素, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:31 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-01-04 ms5000000675684069

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1180403, encodeId=417d11804035c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df896443924, createdName=ms5000000675684069, createdTime=Tue Jan 04 14:32:06 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179607, encodeId=5f3a11e9607f1, content=值得下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:39 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179606, encodeId=55d111e9606ba, content=好东西，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:33 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179605, encodeId=bb7c11e960540, content=主要驱动因素, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:31 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-01-01 一己怀

    值得下载

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1180403, encodeId=417d11804035c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df896443924, createdName=ms5000000675684069, createdTime=Tue Jan 04 14:32:06 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179607, encodeId=5f3a11e9607f1, content=值得下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:39 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179606, encodeId=55d111e9606ba, content=好东西，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:33 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179605, encodeId=bb7c11e960540, content=主要驱动因素, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:31 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-01-01 一己怀

    好东西，谢谢

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1180403, encodeId=417d11804035c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=df896443924, createdName=ms5000000675684069, createdTime=Tue Jan 04 14:32:06 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179607, encodeId=5f3a11e9607f1, content=值得下载, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:39 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179606, encodeId=55d111e9606ba, content=好东西，谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:33 CST 2022, time=2022-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179605, encodeId=bb7c11e960540, content=主要驱动因素, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Sat Jan 01 20:05:31 CST 2022, time=2022-01-01, status=1, ipAttribution=)]
    2022-01-01 一己怀

    主要驱动因素

    0

相关指南

2021 ESGE/ESGENA立场声明：胃肠内镜手术安全检查表实施指导

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2021-12-14

2021 CAG立场声明：丁溴东莨菪碱在胃肠内镜检查期间的应用

加拿大胃肠病学协会(CAG,The Canadian Association of Gastroenterology) · 2021-10-12

2021 AGA指南：SARS-CoV2检测以及疫苗接种后内镜检查（更新）

美国胃肠病协会(AGA,American Gastroenterological Association) · 2021-05-21

2020 ESGE/ESGENA立场声明：胃肠内镜检查和COVID-19流行

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2020-04-17

2019 GESA立场声明：胃肠内镜检查期间应用西甲硅油

澳大利亚胃肠病学会(GESA,Gastroenterological Seciety of Australia) · 2019-06-26

2018 ESGE/ESGENA立场声明：用于胃肠内镜检查的软式消化内镜及附件再处理

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2018-11-20

拓展阅读

2017 SIED意见书：非麻醉医生胃肠内镜检查应用丙泊酚

意大利消化内镜学会(SIED,Italian Society of Digestive Endoscopy) · 2017-09-05

2017 ASGE指南：胃肠内镜检查的镇静和麻醉

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2017-12-23

2018 ASGE指南：胃肠内镜检查期间感染控制

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2018-03-21

2018 ESGE/ESGENA立场声明：用于胃肠内镜检查的软式消化内镜及附件再处理

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2018-11-20

2019 GESA立场声明：胃肠内镜检查期间应用西甲硅油

澳大利亚胃肠病学会(GESA,Gastroenterological Seciety of Australia) · 2019-06-26

2020 ESGE/ESGENA立场声明：胃肠内镜检查和COVID-19流行

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2020-04-17